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EFFECTS OF ANTILYMFHOCTYE SERUM ON ANIMALS 
EXPERIMENTALLY INFECTED WITH HISTOPLASMA 
CAPSULATUM OR CRYPTOCOCCUS NEOFORMANS
CHAPTER I 
INTRODUCTION
The f a c t  t h a t  leucocytes  of one spec ies  could be
destroyed by a n t i s e r a  prepared in  a second species  was f i r s t
descr ibed  by Metchnikoff (21) in  l899« Pappenheimer (23) in  
1917 prepared a n t i s e r a  a g a in s t  r a t  thymocytes i n  r a b b i t s  and 
noted t h a t  such sera  had the a b i l i t y  to a g g lu t in a t e  donor 
lymphocytes and a lso  to ly se  them. Heating of  the se ra  to 
56 C fo r  30 minutes removed the l y t i c  p ro p e r t i e s  of  the sera  
but  f a i l e d  to impair a g g lu t i n a t i o n .  Lymphopenia has been a 
c o n s i s t e n t  f ind ing  in  animals t r e a t e d  with anti lymphocyte  
serum (ALS) and has been well  documented (4 ,  % 26, 3 0 ) « As
the lymphocyte became s t e a d i l y  more in sep a rab le  from the
immune p rocess ,  the important  p o t e n t i a l i t i e s  of ALS became 
e v id e n t .  In 1956, In d e rb i tze n  (11) and Humphrey (10) in  
i 960  used he te ro logous ALS to  d e s t ro y  c i r c u l a t i n g  lympho­
cytes  as a technique fo r  studying the p a r t i c i p a t i o n  of these 
c e l l s  in  the  delayed tu b e r c u l in  r e a c t i o n .  In  1958, Wilhelm
1
2( 3 1 ) used the same technique to study con tac t  s e n s i t i v i t y .
The s tu d ie s  confirmed the growing evidence t h a t  the lympho­
cyte  was a necessary  element fo r  delayed r e a c t i o n s ,  such as 
the tu b e r c u l in  type,  to occur.
Only w i th in  the  l a s t  few years  has the immunosup­
p res s iv e  a c t i v i t y  of ALS become the su b je c t  of in te n se  i n ­
v e s t i g a t i o n .  Antilymphocyte serum in h ib i t e d  cutaneous 
delayed h y p e rs e n s i t iv e  r e a c t io n s  (30) ,  prolonged the s u r ­
v iv a l  of va r ious  t i s s u e  g r a f t s  (1 ,  27) and depressed primary 
immunologic responses (22) .  The s t ro n g ly  growing i n t e r e s t  
in  ALS was due to  i t s  tremendous p o t e n t i a l  use as an 
immunosuppressant fo r  human organ and t i s s u e  t r a n s p l a n t a t i o n .  
S t a r z l  e t  a l .  (27) demonstrated the use fu lness  of ALS in  
prolonging human ren a l  hom otransp lan ts . He d id ,  however, 
r e p o r t  a f a t a l  pneumonitis in  one p a t i e n t  and minor upper 
r e s p i r a t o r y  i n f e c t i o n s  had developed in  o ther  p a t i e n t s  being 
t r e a t e d  with  ALS during t r a n s p l a n t a t i o n  therapy.  Abaza e t  al. 
(1) repo r ted  t h a t  ^ of  8 dogs t r e a t e d  with ALS died from i n ­
f e c t io n ;  two from distemper ,  one from h e p a t i tu s  and one of 
pneumonia even though the dogs had been immunized a g a in s t  
distemper and h e p a t i t u s .
The r e l a t i v e  freedom from i n f e c t i o n  during ALS 
therapy to date  has been due to  s t r i n g e n t  i s o l a t i o n  of the 
p a t i e n t  and a n t i b i o t i c  therapy.  Such p recau t ions  may be i n ­
s u f f i c i e n t  fo r  v i r a l  or fungal  i n f e c t io n s  due to  the l im i te d  
e f f e c t i v e n e s s  of a n t i b i o t i c s  in  these  i n f e c t i o n s .
3Experimental  i n f e c t i o n  s tu d ies  combined with  ALS t rea tm ent  
should be done in  animals to  f u l l y  access  complications and 
hazards which may a r i s e  from i n f e c t i o n  during immunotherapy. 
These r i s k s  might be made more apparent  by experimental  i n ­
f e c t io n  used in  combination with ALS i n  l a b o r a to r y  animals .
There has been no general  agreement on the p r o p e r t i e s  
to  which ALS owes i t s  remarkable immunosuppressive powers.
A number of p o in ts  on which there  has been genera l  agreement 
i s  given below: 1. Antilymphocyte serum has the c h a ra c te r
of an antibody.  Most of i t s  a c t i v i t y  i s  i n  the  IgG (7S) 
serum f r a c t i o n  (12) .  2. Antilymphocyte serum i s  spec ies
s p e c i f i c  (9 ) .  Antilymphocyte serum prepared a g a in s t  the 
lymphoid c e l l s  of one s t r a i n  of mouse w i l l  r e a c t  a g a in s t  
lymphoid c e l l s  of  ano ther  s t r a i n  but w i l l  not  a g g lu t in a t e  
or ly se  lymphoid c e l l s  of r a t s ,  guinea p ig s ,  e tc .
3. Antilymphocyte serum i s  not  d i r e c te d  a g a in s t  an t igens  
p e c u l ia r  to  lymphoid c e l l s  (19).  An an tiserum  prepared 
using mouse t a i l  epidermal c e l l s  has the  p r o p e r t i e s  of ALS 
but  may be l e s s  e f f e c t i v e ,  k. Lymphoid c e l l s  are  the e f ­
f e c t iv e  t a r g e t s  of ALS. Antilymphocyte serum which i s  
f i r s t  absorbed with lymphoid c e l l s  becomes impotent as an 
immunosuppressant (19 ) .  5» Antilymphocyte serum does not
a c t  by causing lymphocytic d e p le t io n .  Homograft s u r v iv a l ,  
fo r  example, p e r s i s t s  long in to  the  period  of lymphoid 
recovery  (1,  12, 17, 18, 33)• 6. The immunosuppressive
e f f e c t s  of ALS o u t l i v e  i t s  own metabolic  l i f e t i m e .  Graf ts
l i v e  f a r  longer than can be accounted fo r  by the presence of 
ALS (22) .  7* Antilymphocyte serum i s  p a r t i c u l a r l y  e f f e c ­
t iv e  i n  c e l l -m ed ia ted  immunities ( l e s s  e f f e c t i v e  i n  suppress ­
ing humoral responses)  (15)* 8. Antilymphocyte serum a f f e c t s
p e r ip h e r a l  lymphocytes (^ ,  5? 26, 30) . For a d i s c u s s io n  of 
these  and o ther  po in ts  see Levey e t  a l .  (19 ) .
Experimental b a c t e r i a l  or mycotic i n f e c t i o n s  in  con­
ju n c t io n  with  ALS t rea tm en t  have not  been r e p o r t e d .  This 
study was designed to  a s se s s  the e f f e c t  of ALS on the degree 
of  s u s c e p t i b i l i t y  of l a b o r a to r y  animals to  experimental  i n ­
f e c t i o n  by two fungal  organisms:  Histoplasma capsulatum
and Cryptococcus neoformans.
Histoplasma capsulatum i s  a d iphas ic  fungus which 
g e n e r a l ly  causes a mild, benign r e s p i r a t o r y  d isease  in  
humans. Rarely, i t  may d issemina te  to o ther  organs causing 
a p ro g re s s iv e ,  chron ic ,  malignant d i sease  which may r e s u l t  
in  dea th .  In mice and guinea p igs ,  r e l a t i v e l y  l a r g e  doses 
given i n t r a p e r i t o n e a l l y  ( i p )  t y p i c a l l y  do not  produce a 
f a t a l  i n f e c t i o n .
Cryptococcus neoformans i s  a budding y e a s t  f r e ­
quen t ly  i s o l a t e d  from n a t u r e . In  humans and animals i t  may 
cause subacute  or chronic i n f e c t i o n  which may inyolve the 
lungs ,  sk in  or o ther  p a r t s  of the body but  has a d i s t i n c t  
p r e d i l e c t i o n  fo r  the  b r a in  and meninges. In c o n t r a s t  to 
H. capsulatum, Ç. neoformans in  r e l a t i v e l y  small  amounts 
w i l l  cause death of mice w i th in  a sho r t  time.  Therefore ,
5H. capsulatum provides an oppor tun i ty  to  study ALS t r e a t e d  
animals with an i n f e c t i n g  organism which g e n e ra l ly  does not  
k i l l  the  ho s t  while Ç. neoformans provides one which can 
very r a p id ly  do so.
Some of the po in ts  which were considered in  t h i s  
study a re  given below: 1. What changes i n  s u s c e p t i b i l i t y
to experimental  i n f e c t i o n  by the two fungal organisms men­
t ioned  occur i n  animals t r e a t e d  with ALS? Does ALS allow 
g re a te r  p r o l i f e r a t i o n  of an i n f e c t i n g  organism i n  t a r g e t  
organs such as l i v e r ,  lungs and spleen? What e f f e c t  on 
m o r ta l i t y  from experimental  i n f e c t i o n  r e s u l t s  from ALS 
t rea tm ent?  How does varying the i n f e c t iv e  dosage or the 
schedule of t rea tm ent  with ALS a f f e c t  m o r ta l i ty ?  Are ALS 
t r e a t e d  animals which are  not  exper im enta l ly  i n f e c te d  more 
prone to acquire  i n f e c t i o n s  due to organisms in  t h e i r  en­
vironment? 2. What e f f e c t  does ALS in  the amounts given in  
t h i s  study have on humoral antibody formation? 3. Is de­
layed type h y p e r s e n s i t i v i t y  (DTH) which normally develops in  
guinea pigs in fe c te d  with H. capsulatum a f f e c te d  by ALS and, 
i f  so, to  what ex tent?  *+. How does ALS a f f e c t  the white 
blood c e l l  and d i f f e r e n t i a l  counts in  guinea pigs and how 
are  these  counts modified by experimental  i n f e c t i o n  with 
H. capsulatum?
In t h i s  study, the terms antilymphocyte serum (ALS) 
and anti thymocyte  serum (ATS) were used in te rchangeab ly .  In 
s tu d ie s  of o ther  workers both a n t i s e r a  have been produced
6a g a in s t  lymphocytes, the  only d i f f e r e n c e  being t h a t  the 
source of lymphocytes fo r  ALS was g e n e ra l ly  from lymph nodes 
while ATS was prepared only a g a in s t  thymic lymphocytes. The 
two se ra  seem to have i d e n t i c a l  p r o p e r t i e s  and fu n c t io n  in  
an i d e n t i c a l  manner as f a r  as i s  known ( ^ ) .
CHAPTER I I  
MATERIALS AND METHODS
Animals Used. Five to seven week old female,
English  Short Hair guinea pigs (Camm Research I n s t i t u t e  I n c . ,  
Wayne, New Je rsey)  were used as thymocyte donors.  Twelve 
week old guinea pigs were used fo r  i n f e c t i o n  s tu d ie s  and 
t rea tm ent  with ALS.
The mice used were Swiss white hybr ids  which are  
maintained in  our l a b o r a to r y .  Both sexes were used.
New Zealand white  r a b b i t s  weighing 2-3 kg were used 
fo r  the  production of a l l  ALS used in  t h i s  s tudy .
Organisms Used. Histoplasma capsula tum. S c r i t c h -  
f i e l d  i s o l a t e ,  o r i g i n a l l y  cu l tu red  from a human case of 
h i s to p la sm o s i s ,  was used. The yeas t  phase of t h i s  organism 
was maintained on Brain Heart  In fus ion  Blood Agar a t  37 C.
The mycelia l  phase of H. capsulatum was maintained on 
Sabouraud's Agar con ta in ing  2% d ex t rose .
For experiments t h a t  involved mice the yeas t  phase 
was used. Yeast c e l l s  from two day old c u l t u r e s  were r e ­
moved from the surface  of Brain Heart  In fu s io n  Blood Agar 
s l a n t s ,  washed in  s a l i n e  th ree  t im es ,  counted, and d i lu t e d
7
8to give suspensions conta in ing  10^ and 10^ c e l l s /m l .  Mice 
were in ocu la ted  in t rav en ou s ly  ( i v )  with 0.1 ml of  the f i r s t  
or second suspension. P la t in g  of s u i t a b l e  d i l u t i o n s  on 
Sabouraud's  Agar {2% dex trose )  showed t h a t  these  two dosages 
r ep re se n te d  7 x 10*+ and 7 x 10^ v ia b le  c e l l s ,  r e s p e c t iv e ly .
The mycelia l  phase of t h i s  organism was used fo r  
i n o c u la t i o n  of guinea p ig s .  One month old c u l tu r e s  were 
h a rv e s te d  from Sabouraud's  Agar s l a n t s  in to  s t e r i l e  s a l i n e ,  
ground with  a Teflon g r in d e r  and d i lu t e d  to  give 1o7 u n i t s /m l
(a u n i t  co ns is ted  of s in g le  or small  clumps of con id ia  with
or with  out hyphal f ragm ents) .  Guinea pigs were inocu la ted
ip with  one ml of the above suspension.  P la t in g  of a p p ro p r i ­
a te  d i l u t i o n s  on Sabouraud's  Agar {2% dex trose)  showed th a t  
t h i s  dosage rep re sen ted  9 x 10^ v iab le  u n i t s .
Cryptococcus neoformans, s t r a i n  18V, i s  a weakly 
encapsu la ted  form of  Ç. neoformans. This organism was main­
ta in e d  in  our l a b o ra to ry  on Sabouraud-s Agar conta in ing  2% 
d ex t ro se .  For i n f e c t i o n  of mice, f l a s k s  of  Neopeptone 
Dextrose D ia lysate  Broth (7) were ino cu la ted  and grown a t  
30 C with  cons tan t  shaking fo r  three  days. The c e l l s  were 
then counted and d i lu t e d  in  s a l i n e .  Mice rece ived  e i t h e r
1 LD^q (2 .2  X 10^) or 0.1 LDjq (2 .2  x 10*+) organisms iv 
conta ined in  0.1 ml. The v i a b i l i t y  was c a lc u la t e d  to be 30% 
when c e l l s  of  Ç. neoformans were d i lu t e d  in  s a l i n e ,  p la ted  
on Sabouraud's  Agar with 2% dex t ro se ,  and grown a t  37 0 for
2 days.
9Determination of LD^g. P re l im inary  s tu d ie s  using 
120 mice were done to  determine the 28 day LD^g f o r  the 
s t r a i n  of Ç. neoformans used. C a lc u la t io n s  were performed 
according to  the  method of Reed and Muench (24) .
P re p a ra t io n  of Antilymphocyte Serum. Two d i f f e r e n t  
p rep a ra t io n s  were used in  t h i s  s tudy but both were prepared 
in  e s s e n t i a l l y  the  same manner.
a .  Rabbit a n t i -g u in e a  pig lymphocyte serum was p re ­
pared by removing the  thymuses of 5-7 week old guinea p igs .  
The organs were then v e in - s t r i p p e d  and c a r e f u l l y  p ressed  
through a f i n e  s t a i n l e s s  s t e e l  mesh in to  cold s a l i n e .  The 
thymocytes were then washed th ree  times in  cold s a l i n e  and 
resuspended to  a con cen tra t ion  5 x 10^ c e l l s /m l .  Four New 
Zealand white  r a b b i t s  were in o cu la ted  iv  with two ml (10^ 
c e l l s )  of  the  suspension.  Two weeks l a t e r  the procedure was 
repea ted .  The fol lowing week a l l  r a b b i t s  were bled from the 
c e n t r a l  ear  a r t e r y  using a 20 gauge needle .  F i f t y  to s ix ty  
ml of blood were taken from each r a b b i t .  One week l a t e r  the 
r a b b i t s  rece ived  5 x 10® thymocytes iv  and were b led ,  as 
above, seven days l a t e r .  Two days l a t e r ,  a l l  r a b b i t s  were 
exsanguinated by ca rd iac  puncture .  All  sera  was s to re d  a t  
-20 C u n t i l  the  l a s t  batch was c o l l e c t e d .  At t h i s  time the 
se ra  were thawed, heated  to %  C fo r  30 min, f i l t e r  s t e r i ­
l i z e d  (M i l l i p o r e ) ,  cu l tu red  fo r  s t e r i l i t y  and s to red  in  10 ml 
amounts a t  -20 C u n t i l  needed.
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b. Rabbit anti-mouse lymphocyte serum was prepared 
as above except t h a t  mouse thymuses were used. The thymuses 
of  f iv e  mice fu rn ished  approximately  10^ c e l l s .  Mice four  
weeks old were used as donors; thymic in v o lu t io n  occurs 
r a p id ly  in  mice o lder  than t h i s .
Thymic p rep a ra t ion s  were t e s t e d  fo r  v i a b i l i t y  by 
adding one drop of f r e s h ly  made t rypan  b lue ,  0.2%, to  a drop 
of thymocyte suspension ,  mixing and examining under 40X 
power. V i a b i l i t y  was then determined by counting dead 
( s t a in e d )  and l i v i n g  (uns ta ined)  c e l l s .  Viable c e l l s  should 
be used fo r  p repar ing  ALS (16) .  P rep a ra t ion s  made using the 
technique above r e g u l a r ly  produced thymocyte suspensions 
which were 95^ v ia b le .
Leucocyte A gg lu t ina t ion  T e s t s . A m od if ica t ion  of the 
method of  Amos and Peacocke (3) was used. Thymocyte p rep a ra ­
t io n s  were washed i n  0 .15 M s a l in e  th ree  times and the c e l l s  
then d i lu t e d  to  2 x lO^/ml in  bu f fe r  prepared as fo l low s:
Mix so lu t io n  A (1 .3  g Na2HP0^, 3*0 g Nai^EDTA/^00 ml 0.1 5 M 
s a l in e )  with s o lu t io n  B (1 .3  g NaH2P0^_/500 ml 0.1 5 M s a l in e )  
to  ob ta in  pH 7* Equal volumes (0.1 ml) of c e l l s  and s e r i a l  
d i l u t i o n s  of serum were mixed in  9 x 75 nim tubes and read 
fo r  macroscopic a g g lu t in a t io n  by gen t le  mixing a f t e r  s tand­
ing 2 h r  a t  room temperature .  The t i t e r  obta ined was a 
measure of leucocyte  a g g lu t in a t in g  an t ibody  of  the pooled 
ALS. The procedure was the same fo r  both ant i-mouse and 
a n t i -g u in e a  pig ALS except the source of the  donor
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lymphocytes. Spleen c e l l s  were t e s t e d  in  the  same manner. 
Lymphoid c e l l s  in  b u f fe r  only served as a c o n t ro l .
C y to to x ic i ty  T e s t i n g . The method of Gray e t  a l .  (9) 
was used. Two drops of s a l in e  were placed in  a r ing  formed 
by Vaseline petroleum j e l l y  on a g la s s  s l i d e .  Thymuses were 
c le a n ly  cut  and the end cut  r e p e a te d ly  touched to the s a l i n e .  
The cy to tox ic  a c t i v i t y  of ALS was determined by adding an 
equal volume of serum and incuba t ing  30 min a t  37 C. Trypan 
blue  {0.2%)  was added and the v i a b i l i t y  determined. Normal 
r a b b i t  serum was used as a c o n t ro l .
White Blood C e l l  (WBC) and D i f f e r e n t i a l  Counts.
a. Guinea pigs
All guinea pigs were bled by card iac  puncture 
p r i o r  to  t rea tm ent .  One p o r t io n  of the  blood was hepa r ina ted  
fo r  WBC counts .  Microhemtocri t de te rm ina t ions  were a lso  per­
formed on t h i s  sample. Blood smears were a l s o  prepared a t  
t h i s  t ime. A second p o r t io n  of the blood was allowed to  c lo t  
and the serum s to red  a t  -20 C u n t i l  needed. This e n t i r e  pro­
cedure was repea ted  weekly fo r  f iv e  weeks a f t e r  i n i t i a t i o n  
of  t rea tm en t ,
b , Mice
Mice were sub jec ted  to t o t a l  WBC counts and d i f ­
f e r e n t i a l s  before and a f t e r  ALS t rea tm en t  to determine the 
e f f e c t i v e n e s s  of  serum t rea tm en t .  An i n e f f e c t i v e  ALS prep­
a r a t i o n  would f a i l  to  produce lymphopenia.
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P r e c i p i t i n  T e s t i n g . Serum c o l l e c te d  from guinea 
pigs a t  weekly i n t e r v a l s  was run a g a in s t  a s e r i e s  of h i s t o ­
plasmin an t igens  prepared as descr ibed  e a r l i e r  ( 2 ) .
The above serum samples a l s o  were t e s t e d  a g a in s t  
normal r a b b i t  serum. By so doing, i t  was p oss ib le  to  
demonstrate  humoral an tibody product ion  in  ALS t r e a t e d  
a n im a ls .
Hemolytic Plaque Assay Technique. Plaque assay  
t e s t s  were performed in  a manner s im i l a r  to t h a t  o r i g i n a l l y  
desc r ibed  by Jerne e t  a l .  (1 3 ) .  This procedure was done to 
measure the  e f f e c t  of ALS on plaque forming c e l l s  (PFC) and 
thus on the  c e l l u l a r  immune response .
T h i r ty  mice were used. Ten mice were in o cu la ted  
with  ip  with 0.25 ml ALS the day b e fo re ,  the day o f ,  and the 
day a f t e r  r ec e iv ing  ip  1 ml of a 2% washed SRBC suspension.
The second group of mice rece ived  normal r a b b i t  serum (NRS)
and SRBCs as above and a t h i r d  group rece ived  only SRBCs.
On the fo u r th  day a f t e r  immunization with SRBCs the spleens 
of a l l  mice were removed, teased  i n to  cold Hank's balanced 
s a l t  s o l u t io n ,  and s t r a in e d  through a f in e  s t a i n l e s s  s t e e l  
mesh. One t en th  ml of a 1 to  10 d i l u t i o n  of sp leen  c e l l s
was added to  1.9 ml of 0.75% agar s o lu t io n  i n  Hank's con­
t a in in g  2 mg of d ie thylara inoe thyl  dex tran  (Pharmacia, 
Uppsala, Sweden). This suspens ion  was then decanted onto a 
l a y e r  of \ .5% agar  in  Hank's s o lu t io n  and spread evenly by 
s w i r l in g .  After  s tand ing  a t  room temperature  fo r  1 5 min the
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p l a t e s  were incubated a t  37 C fo r  1 h r .  A 1:10 d i l u t i o n  of
guinea pig complement, 1.5  m l /p la t e ,  was added and the p l a t e s
were re incubated  a t  37 C fo r  an a d d i t i o n a l  30 min. The 
p l a t e s  were then placed a t  room temperature  fo r  two hours .
The excess complement was then decanted and the p l a t e s  
s to re d  a t  h C ove rn igh t .  The p l a t e s  were s ta in e d  by adding 
2 ml of the fo l lowing mixture:  a .  10 ml of 2% benzidine
s o lu t io n  in  g l a c i a l  a c e t i c  acid  with  0 .5  ml of  30^ hydrogen 
peroxide,  b. 90 ml of d i s t i l l e d  water .  The p la t e s  were
incubated u n t i l  a blue color  developed.  The so lu t io n  was
then poured o f f  and the plaques counted under a s te reoscope  
(O.7X o c u l a r ) .
In f e c t io n  of Mice with Cryptococcus neoformans. One 
hundred and f i f t y  mice, 8 weeks old and of both sexes were 
used. The mice were placed in  3 main d i v i s io n s .  The f i r s t  
d iv i s io n  cons is ted  of 80 mice, 10 in  each group. All  members 
of t h i s  d iv i s io n  rece ived  3 ip  i n j e c t i o n s ,  0 .25 ml ALS/ 
i n j e c t i o n .  Four groups were t r e a t e d  with ALS the day be fo re ,  
the day o f ,  and the day a f t e r  i n f e c t i o n  (days -1 ,  0 and 1). 
These mice were in fe c te d  with e i t h e r  0 .!  or 1 LD^q. Two 
o ther  groups were t r e a t e d  with ALS i n  the same manner. One 
group rece ived  nonviable {2% fo rm al in  and hea t  k i l l e d )  c e l l s  
and the o ther  group rece ived  no c e l l s  (ALS c o n t r o l ) .  Two 
a d d i t i o n a l  groups were given 1 LD^g on day 0. The f i r s t  
group rece ived  ALS on days 0, 1 and 2 and the second group 
rece ived  ALS on days 7, 8, and 9 pos t  i n f e c t io n .
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In the second d i v i s io n ,  the t rea tm en t  of  mice was 
s im i la r  except normal r a b b i t  serum (NRS) was used in s te a d  of 
ALS.
In the t h i r d  d iv i s io n  only 2 groups (20 mice) were 
used. The f i r s t  group was given 1 LD^q; the second group 
rece ived  0.1 t h i s  dosage. These mice had no serum t rea tm en t .
The 1 LD^q g iven enabled d i r e c t  comparisons of ALS, 
NRS, and non-serum t r e a t e d  animals i n f e c te d  with  Ç. 
neoformans using a known re fe ren ce  p o in t .  The 0.1 LD^q was 
used p r im ar i ly  to determine i f  such a low dosage would k i l l  
the ALS t r e a t e d  mice. Complete d e t a i l s  of t h i s  experiment 
are  shown in  Table 1.
In fe c t io n  of Mice with Histoplasma capsulatum. One 
hundred and ten  mice, 8 weeks old and of both sexes were 
used. The mice were placed in  3 main d i v i s io n s .  The f i r s t  
d i v i s io n  cons is ted  of 40 mice, 10 in  each group. Each of 
these  mice rece ived  3 ip  i n j e c t i o n s  of ALS a t  days -1 ,  0, 
and 1 and were i n f e c te d  on day 0. Half  of the  mice in  t h i s  
d i v i s io n  received  10^ y e a s t  c e l l s  of H. capsulatum iv .  The 
second h a l f  rece ived  10^ y eas t  c e l l s  iv .
The second d iv i s io n  a lso  con s is ted  of 40 mice. Half  
rece ived  10^ y e a s t  c e l l s  iv  while the second h a l f  rece ived  
10^ c e l l s  iv .  These mice were serum t r e a t e d  as above except 
t h a t  normal r a b b i t  serum was used in s te a d  of ALS.
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T a b l e  1 .  S c h e d u l e  f o r  s e r u m  t r e a t m e n t  a n d  i n f e c t i o n  o f  m i c e
w i t h  C .  n e o f o r m a n s
Serum
Treatment*
Days
given**
Dosage
in
^ ^ 5 0 ' s
V i a b i l i t y  
of  ce l ls***
Route
given
No. mice/  
group
ALS -1 0,1 1 V iv 10
ALS -1 0,1 1 V iv 10
ALS -1 0,1 0.1 V iv 10
ALS -1 0,1 0.1 V iv 10
ALS -1 0,1 — — — iv 10
ALS 0 1,2 1 V iv 10
ALS 7 8,9 1 V iv 10
ALS -1 0,1 1 NV iv 10
NRS -1 0,1 1 V iv 10
NRS -1 0,1 0.1 V iv 10
NRS -1 0,1 1 NV iv 10
NRS -1 0,1 — — “ ------------ iv 10
NRS 7 8,9 1 V iv 10
Sal ine -1 0,1 0.1 V iv 10
Sal ine -1 0,1 1 V iv 10
*ALS .= Antilymphocyte Serum.
NRS= Normal Rabbit Serum.
**Days serum trea tm en t  adm in is te red  r e l a t i v e  to  i n ­
f e c t i o n  on day 0.
= v iab le  c e l l s .  NV= non v i a b l e .
1 6
The t h i r d  d i v i s io n  cons is ted  of 30 mice. These mice 
rece ived  no serum t rea tm en t .  Ten mice were in ocu la ted  iv  
with 10*^  y e as t  c e l l s ;  twenty rece ived  10^ c e l l s  i v ,  as in  
Table 2.
The h igh  dosage (10?) was used to  determine i f  any 
d i f f e r e n c e s  could be observed in  ALS and NRS t r e a t e d  animals ,  
as compared with  c o n t r o l s ,  when an overwhelming i n f e c t i o n  
was in troduced .  The 10^ dosage was employed p r im a r i ly  to 
c rea te  an i n f e c t i o n  but  without r a p id  death  (as in  the high 
dosage).  Thus, l i v e r ,  lungs ,  and sp leen ,  t y p i c a l l y  involved 
in  h i s to p la sm o s i s ,  were removed from some members of t h i s  
group a t  2 weeks and from o thers  a t  *+ weeks post  i n f e c t i o n  
and q u a n t i t a t i v e l y  c u l tu r e d .  The ex ten t  of  p r o l i f e r a t i o n  of 
H. capsulatum was compared in  ALS, NRS, and u n t rea te d  con­
t r o l s  .
Skin Tes ts  i n  Guinea Pigs In fec ted  with H. 
capsulatum. Four groups of guinea pigs in o cu la ted  four  
weeks e a r l i e r  with  9 x 1 0 ^  v ia b le  mycelia l  p a r t i c l e s  of H. 
capsulatum were used.  Group one rece ived  two i n j e c t i o n s  of 
ALS p r io r  to  i n f e c t i o n  and weekly t h e r e a f t e r .  Group two r e ­
ceived NRS r a t h e r  than  ALS. Groups th ree  and four were 
t r e a t e d  with s a l in e  on the same schedule as the o ther  groups 
except group four  rece ived  one a d d i t i o n a l  i n j e c t i o n ,  ALS, 
the  n ig h t  before  sk in  t e s t i n g .  Table 3 shows d e t a i l s  of t h i s  
experiment.
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T a b l e  2 ,  S c h e d u l e  f o r  s e r u m  t r e a t m e n t  a n d  i n f e c t i o n  o f  m i c e
w i t h  H.  c a p s u l a t u m
Serum
Treatment*
Days
given**
No.
c e l l s
given
V i a b i l i t y  
of ce l ls***
Route
given
No. mice/ 
group
ALS -1 ,0 ,1 10^ V iv 10
ALS -1 ,0 ,1 10^ V iv 10
ALS -1 ,0 ,1 10? V iv 10
ALS -1 ,0 ,1 107 V iv 10
NRS -1 ,0 ,1 10^ V iv 10
NRS -1 ,0 ,1 10^ V iv 10
NRS -1 ,0 ,1 1o7 V iv 10
NRS -1 ,0 ,1 10^ V iv 10
Sal ine -1 ,0 ,1 10^ V iv 10
Sal ine -1 ,0 ,1 10^ V iv 10
Sal ine -1 ,0 ,1 10^ V iv 10
*ALS= anti lymphocyte  serum.
NRS= normal r a b b i t  serum.
**Days serum t rea tm ent  adminis tered  r e l a t i v e  to i n ­
f e c t i o n  on day 0.
***V= v ia b le  c e l l s  given.
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T a b l e  3 -  S c h e d u l e  f o r  b l e e d i n g ,  s e r u m  t r e a t m e n t  a n d  i n o c u ­
l a t i o n  o f  g u i n e a  p i g s  w i t h  H.  c a p s u l a t u m
Day** Group 1 Group 2 Group 3 Group 4 Group 5
-7 Bled Bled Bled Bled Bled
ALS NRS Sal ine Sal ine ALS
-2 ALS NRS Saline Sal ine ALS
-1 Bled Bled Bled Bled Bled
0 In fec ted In fec ted In fec ted In fec ted Sal ine
6 ALS NRS Sal ine Sal ine ALS
7 Bled Bled Bled Bled Bled
13 ALS NRS Sal ine Sal ine ALS
14 Bled Bled Bled Bled Bled
19 ALS NRS Sal ine Sal ine ALS
20 Bled Bled Bled Bled Bled
26 ALS NRS Sal ine Sal ine ALS
27 Bled Bled Bled Bled Bled
33 ALS NRS Sal ine Sal ine ALS
34 Bled Bled Bled Bled Bled
40 ALS NRS Sal ine Sal ine ALS
41 Bled Bled Bled Bled Bled
43 ALS
44 ST* ST ST ST ST
*ST=sk in  t e s t e d ,  0.1 ml h is top la sm in  id .
**Indica tes  day r e l a t i v e  to  day of  i n f e c t i o n  (day 0) .
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Determination of Local I n h i b i t i o n  of Delayed Hyper­
s e n s i t i v i t y . To determine i f  delayed type h y p e r s e n s i t i v i t y  
could be i n h ib i t e d  l o c a l l y  by in t rad e rm al  ( i d )  i n j e c t i o n  of 
ALS, 10 guinea pigs with known p o s i t i v e  sk in  t e s t s  were used. 
Both abdominal s id e s  were shaved. On one s id e ,  h i s top la sm in  
( l o t  H-1+2, produced by United S ta te s  Public  Heal th  S e rv ice ) ,  
1:25 d i l u t i o n ,  was inocu la ted  id .  At d i s ta n c e s  of from 25 to 
mm from t h i s  s i t e ,  ALS was given i d .  A second i n j e c t i o n  
of  h i s to p la sm in  was given as a c o n t ro l  a t  l e a s t  100 mm d i s ­
t a n t  from the ALS i n j e c t i o n  s i t e .  I n d u ra t io n  and erythema 
were measured a t  2k and ^8 hours .  As an a l t e r n a t e  s tudy,
ALS was given id  and 2k hours l a t e r  h is to p la sm in  was i n j e c t e d  
near  the  f i r s t  i n j e c t i o n  s i t e .  Normal r a b b i t  serum was i n ­
cluded as a c o n t ro l .
CHAPTER I I I  
RESULTS
L eucoagglu t ina t ion  T e s t s .
a . Guinea pigs
The leu c o a g g lu t in a t io n  t i t e r  of  ALS prepared 
a g a in s t  guinea pigs was found to  be 1:512  when t e s t e d  a g a in s t  
guinea pig thymocytes. When the same an t ise rum  was t e s t e d  
a g a i n s t  lymphocytes derived  from sp le n ic  o r ig in ,  the t i t e r  
was 1 :256. This serum was a l s o  run a g a in s t  sp leen  and 
thymic lymphocytes from donor mice. No a g g lu t in a t io n  was 
observed in  t e s t s  invo lv ing  he te ro logous c e l l s .  Guinea pig 
lymphoid c e l l s ,  run as c o n t r o l s ,  i n  b u f f e r  alone or in  
b u f f e r  plus normal r a b b i t  serum were not a g g lu t in a te d .  
Lymphoid c e l l  p rep a ra t io n s  for  l e u c o a g g lu t in in  t e s t s  must 
be used w ith in  a few hours as a u to a g g lu t in a t i o n  occurred 
when c e l l s  were s to re d  fo r  longer  pe r iods .
b. Mice
Similar  r e s u l t s  were obtained when ALS prepared 
a g a in s t  mouse thymocytes was t e s t e d .  The leu c o a g g lu t in a t io n  
t i t e r  a g a in s t  mouse thymocytes was 1:256 and a g a in s t  mouse 
sp leen  c e l l s  was 1:128. Fresh thymic or sp leen  c e l l s  did
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not  a g g lu t in a te  i n  b u f fe r  alone or in  b u f fe r  plus normal 
r a b b i t  serum. Lymphoid c e l l s  from guinea pig donors f a i l e d  
to  a g g lu t in a t e  i n  the presence of r a b b i t  anti-mouse lympho­
cyte  serum.
C y to to x ic i ty  T e s t s . The r e s u l t s  of these  t e s t s  
showed t h a t  ALS prepared a g a in s t  both guinea pig and mouse 
thymocytes had the a b i l i t y  to cause l y s i s  and death  ( a s c e r ­
ta ined  by the i n a b i l i t y  to  exclude t rypan  blue dye) of 
lymphoid c e l l s  in  the presence of complement. F i f t y  percent  
of  the lymphocytes exposed to ALS were k i l l e d  w i tb in  30 
minutes as compared to 10^ in  co n t ro l s  which conta ined 
normal r a b b i t  serum in s te a d  of ALS. Results  of leucocyto-  
t o x i c i t y  t e s t s  of both guinea pig and mouse thymocytes are  
shown in  Table 4.
P r e c i p i t i n  T e s t s . Four out of  35 guinea pigs i n ­
fe c te d  with  H. capsulatum had se ra  t h a t  r ea c ted  p o s i t i v e l y  
with crude h i s to p la sm in .  One animal which had a p o s i t iv e  
response had been t r e a t e d  weekly with ALS; the o ther  th ree  
animals which responded p o s i t i v e l y  had received  s a l in e .
All  guinea pigs which had been t r e a t e d  with NRS 
weekly had p r e c i p i t i n  bands a g a in s t  some components of NRS 
a f t e r  two weeks of such t rea tm en t .  All guinea pigs which 
had been t r e a te d  with ALS weekly a lso  showed p r e c i p i t i n s  
a g a in s t  NRS. Some of these  se ra  showed as many as f iv e  
p r e c i p i t i n  bands a g a in s t  NRS, two more than seen in  t e s t s  
with  any serum of NRS t r e a t e d  guinea pigs .
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Table C y to to x ic i ty  of ALS a g a in s t  thymocytes as assayed
by t rypan  blue exclusion
Thymocytes
from;
Percent  v iab le  c e l l s  a f t e r  in cu b a t io n  with 
complement fo r  30 min i n  the  presence of
RAMLS* RAGPL8++ NRS*** SALINE
Guinea pig 90 50 94 92
Mouse >+3 87 90 94
*Rabbit anti -mouse lymphocyte serum.
**Rabbit a n t i -g u in e a  pig lymphocyte serum.
***Normal r a b b i t  serum.
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White Blood C e l l  Counts.
a. Guinea pigs
Normal white blood c e l l  (WBC) counts fo r  guinea 
pigs used were in  a range of 3,500 to  13,000/mm3, with  most 
of the  animals having a count of 7,000 ± 2 , 000/mm^. The 
mean count in  normal con t ro l s  was 7,100 cells/mm^. Animals 
t r e a t e d  with ALS ex h ib i ted  a s h o r t - l i v e d  leucopenia  and 
counts u su a l ly  dropped 3,000 to  If,000 cells/mm^ w i th in  a few 
hours  of t r ea tm en t .  This was followed by a moderate 
l e u c o cy to s i s  w i th in  a day or two which peaked a t  2 weeks 
a f t e r  i n i t i a l  t rea tm e n t .  All i n f e c t e d  animals r e g a r d l e s s  i f  
they were ALS, NRS or s a l i n e  t r e a t e d  showed the same genera l  
t r end :  a moderate l e u c o cy to s i s  developed w i th in  1-2 weeks
post  i n f e c t i o n  and s h o r t l y  t h e r e a f t e r  began to  r e t u r n  to 
normal v a lues .  Resu l ts  are  i l l u s t r a t e d  in  Figure  1.
b . Mice
Normal mice were h ig h ly  v a r i a b l e .  Counts ranged 
from 6,200 to 19,600/mm^. After  3 i n j e c t i o n s  of ALS, 0 .25  ml 
each, ip ,  given d a i l y  fo r  3 consecu t ive  days the t o t a l  white 
count average was only moderately in c re a sed .  The mean p re ­
t rea tm en t  white count was 9,100; s h o r t l y  following completion 
of ALS t rea tm ent  the mean count had inc reased  to  19,700.
White counts r e tu rn e d  to  normal in  about 10 days.
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Figure 1. E f fec t  of  i n f e c t i o n  with  H. capsulatum on 
white blood c e l l  counts of guinea pigs t r e a t e d  with a n t i ­
lymphocyte serum (ALS), normal r a b b i t  serum (NRS) or s a l i n e .
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D i f f e r e n t i a l  Blood Counts
a .  Guinea pigs
Guinea pigs t r e a t e d  with ALS showed a marked de­
crease  i n  percentage of  lymphocytes w i th in  24 hours .  
Lymphopenia was pronounced fo r  two weeks i n  non in fec ted  con­
t r o l s  with  percen t  lymphocytes f a l l i n g  from 66 to 14. This 
t rend  f a i l e d  to continue ,  however, r e g a rd le s s  of weekly ad­
m in i s t r a t i o n  of ALS. Four weeks a f t e r  commencement of  ALS 
trea tm ent  the lymphocyte percentage had re tu rned  to  w i th in  
of i t s  normal base l i n e  average.
Animals which were ALS t r e a t e d  and a lso  in fe c te d  
showed severe lymphopenia but  the r e t u r n  toward normal was 
more gradual  than in  noninfec ted  c o n t ro l s .
The groups of guinea pigs which were treated with 
NRS weekly or with s a l in e  showed only s l i g h t  lymphopenia 
which could be a t t r i b u t e d  to  i n f e c t i o n  with H. capsula tum. 
Figure 2 shows the r e l a t i o n s h i p s  among the va r ious  groups.
Figure  3 shows t h a t  the severe lymphopenia in  ALS 
co n t ro l s  was almost  a mirror  image r e f l e x io n  on n e u t r o p h i l i c  
h y p e rp la s i a .  Basophils  and monocytes f l u c tu a t e d  only 
s l i g h t l y  and were not included in  t h i s  f i g u r e .  A no tab le  
e o s in o p h i l i a  was observed only in  animals which had received  
serum t rea tm ent .
Figure  4 which r e p re se n ts  an in fec te d  and ALS weekly 
t r e a t e d  group shows somewhat the same p a t t e r n  as Figure  3-
2 6
ALS CONTROL
—  O ALS
■  — SALINE
.  40-
O
X
u
O
i 3 0 '
E
X
2 0
W E E  KS
Figure 2. E f fe c t  of  antilymphocyte  serum (ALS), 
normal r a b b i t  serum (NRS) or s a l i n e  on p e r ip h e ra l  lymphocyte 
counts of guinea pigs in fec te d  with H. capsulatum.
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Figure  3. E f fe c t  of  anti lymphocyte  serum on pe r iph ­
e r a l  lymphocyte, n e u t r o p h i l  and eos inoph i l  counts of normal 
guinea p igs .
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Figure 4. E f f e c t  of anti lymphocyte  serum (ALS) 
on p e r ip h e r a l  lymphocyte, n e u t ro p h i l  and eos inoph i l  counts 
o f  guinea pigs in f e c te d  with H. capsulatum.
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Lymphocyte percentage decreases r a p id ly  and t h i s  decrease i s  
compensated by an in c rease  in  n e u t r o p h i l s .  After  two weeks 
the two c e l l  types have switched places  with r e s p e c t  to  t h e i r  
normal base l i n e  percen tages .  A gradual r e v e r s a l  then oc­
curred as each c e l l  type began to  r e t u r n  toward i t s  normal 
concen tra t ion .
Figures 5 and 6 r e p re se n t in g  animals in fec te d  and 
t r e a t e d  with NRS and animals in fec te d  and t r e a t e d  with 
s a l in e  r e s p e c t iv e ly ,  show only gradual decreases in  percent  
lymphocytes with compensating in c reases  i n  n e u t ro p h i l s .
Microhematocri t de te rmina t ions  showed t h a t  the mean 
hematocr i t  dropped only th ree  to  four  pe rcen t  two or th ree  
weeks a f t e r  i n f e c t i o n .  These values r e tu rned  to  t h e i r  normal 
average (43%) w i th in  f iv e  weeks,
b. Mice
D i f f e r e n t i a l  counts performed on normal mice 
revea led  the fol lowing va lues :  n e u t r o p h i l s ,  21%; lympho­
c y te s ,  74%; monocytes, 4^; e o s in o ph i l s ,  1%. After  th ree  
consecutive d a i ly  doses,  0 .25 ml ALS/dose given ip ,  the 
following values were obtained:  n e u t r o p h i l s ,  56%; lympho­
c y te s ,  38%; monocytes 3%; e o s in o ph i l s ,  3%* Marked 
a n iso cy to s i s  and p o ik i lo c y to s i s  were ev iden t .
E ffec t  of I n t r a p e r i t o n e a l  In o cu la t io n  of ALS on 
Delayed Type H y p e r s e n s i t iv i ty  (DTK). L i t t l e  e f f e c t  was 
produced by weekly i n j e c t i o n s  of guinea pigs with ALS. The 
mean in d u ra t io n  of sk in  t e s t  readings measured in
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Figure  5* E f fe c t  of  normal r a b b i t  serum on p e r ip h ­
e r a l  lymphocyte, n e u t r o p h i l  and eos inoph i l  counts in  guinea 
pigs in fe c te d  with  H. capsula tum.
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Figure  6. E f f e c t  of i n f e c t i o n  with  H. capsulatum on 
p e r ip h e r a l  lymphocyte and n e u t ro p h i l  counts of guinea p igs .
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m il l im e te rs  was 7 . 6  x 8 .2 .  This was somewhat l e s s  than  a n i ­
mals t r e a t e d  with  NRS weekly (10.1 x 11.1) or s a l in e  
(11 .4  X 11.4) .  Marked suppress ion  was e x h ib i t ed ,  however, 
in  the group which rece ived  only one i n j e c t i o n  of  ALS on the 
n igh t  before  sk in  t e s t i n g .  The mean 24 hour in d u ra t io n  fo r  
t h i s  group was I .7  x 1.8 mm. Resu l ts  a re  shown in  Table 5«
For purposes of comparison, the  area  of in d u ra t io n  
(lA) was c a lc u l a t e d .  The formula, lA = where D1
and D2 are  two measurements of i n d u ra t io n  made perpend icu lar  
to  one ano ther ,  was used. The mean a rea  of in d u ra t io n ,  or 
in d u ra t io n  index ( I I )  then would be expressed as:
I I  = w h e r e  n  e q u a l s  t h e  n u m b e r  o f  a n i m a l s  t e s t e d .
n
The minimum p o s i t i v e  value fo r  I I  was defined as 19*75? 
choosing a r b i t r a r i l y  to l e t  D1 and D2 both equal 5 ( th e  
minimum al lowable  measurement which was considered as p o s i ­
t iv e )  . The 24 hour I I  fo r  animals t r e a t e d  with ALS weekly 
was 52 . 9 ? fo r  animals t h a t  rece ived  NRS weekly, 96 .1 ;  fo r  
s a l in e  t r e a t e d  animals ,  139*3; fo r  animals which rece ived  
s a l in e  except  fo r  a s ing le  i n j e c t i o n  of ALS the n ig h t  before  
sk in  t e s t i n g ;  3*5* Table 5 gives va lues  fo r  these  readings 
and fo r  48 hour readings as w e l l .  The number of sk in  t e s t  
p o s i t iv e  animals involved in  the  four  groups above are  shown 
in  Table 6.
E f fe c t  of ALS Given In t rade rm al lv  on DTK. In guinea 
pigs in fe c te d  with H. capsulatum, ALS given id  markedly de­
pressed the delayed skin  r e a c t io n .  As seen in  Table 7? the
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Table 5* E f fec t  of antilymphocyte  serum given i n t r a p e r i t o -  
n e a l ly  on delayed sk in  r e a c t iv i ty  i n  guinea pigs in fe c te d
with  H. capsulatum
2k hr Indura t ion 48 hr Indu ra t io n
Treatment D1* D2 II** D1 D2 II
In fec ted ,
weekly
NRS
11.1 10.1 96.1 9 . 5 8.6 7 3 .2
In fec ted ,
weekly
sa l in e
11 .k 11 139.3 9 . 5 8.0 100.3
In fec ted ,
weekly
ALS
8.2 7.6 52.9 5.6 5.6 28 . 9
In f e c te d ,  ALS 
nigh t  before  
only 1.8 1.7 3 . 5 2 . 5 ■2 . 5 8 .3
^Represents a measurement in  mm of in d u ra t io n  while 
D2 i s  a second measurement made perpend icu lar  to  the f i r s t .  
These f ig u re s  a re  means of the  groups in d ic a te d .
**Represents the mean area  of in d u ra t io n .
ALS = anti lymphocyte serum. -
NRS = normal r a b b i t  serum.
3 ^
Table 6. Resul ts  of sk in  t e s t s  in  guinea p igs  in f e c te d  with
H. capsulatum
In d u ra t io n Erythema
Treatment 2h h r ^8 hr 24- h r 48 hr
ALS weekly 3 /5 4 /5 4/5
NRS weekly 10/10 8/10 10/10 8/10
S a line  weekly 10/10 8/10 10/10 8/10
ALS, n ig h t before  
only 0/10 1/10 7/10 6/10
^Ind ica te s  the number of guinea pigs having p o s i t iv e  
sk in  t e s t  readings  ( a t  l e a s t  19-75 mm^ ) over the t o t a l  
number t e s t e d .
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e f f e c t s  of  ALS are  not l im i te d  to  a small a rea  around the 
s i t e  of  i n j e c t i o n .  Skin r e a c t i v i t y  to  h is top lasm in  was i n ­
h i b i t e d ,  u s u a l ly  completely , w i th in  a rad iu s  of 40 mm. At 
d i s tan c es  g re a te r  than 40 mm l i t t l e  or no e f f e c t  on sk in  
t e s t  r e a c t i v i t y  was apparen t .
When h is top lasm in  was i n j e c t e d  in  the v i c i n i t y  of 
the ALS i n j e c t i o n  s i t e  but  k8 hours l a t e r ,  the delayed skin  
t e s t  r e a c t i o n  was s t i l l  suppressed.  This suppress ive  e f f e c t  
had u s u a l ly  disappeared w i th in  72 hours .
I n f e c t io n  of Mice with C_. neoformans. Mice were 
in o cu la ted  iv  with  a high dose (2 .2  x 10^ c e l l s )  or a low 
dose (2 .2  X 10^ c e l l s )  on day zero (except  fo r  co n t ro l s  
which were not in o c u la te d ) .  These dosages r ep re sen ted  
1 LD^o and 0.1 LD^q? r e s p e c t iv e ly  fo r  28 days. I t  was found 
t h a t  mice t r e a t e d  with ALS on days -1 ,  0, and 1, and in fe c te d  
with 1 LD^o died more r a p id ly  than any o ther  group. On day 
17 ( p o s t  i n f e c t i o n )  50^ of the mice in  t h i s  group were dead. 
Mice i n f e c te d  with  1 LD^q and t r e a t e d  with ALS on days 7, 8, 
and 9 had 50^ deaths  by day 20. Mice in fe c te d  with 0.1 LD^q 
and rece ived  ALS on days -1 ,  0, and 1 had 50^ deaths on day 
2k.  Only 1 mouse th a t  had rece ived  ALS but no i n f e c t i n g  
dose (ALS co n t ro l )  died w i th in  24 days. Table 8 shows these 
da ta .
Twenty percent  of the mice t r e a t e d  with WRS and 
i n f e c te d  with  e i t h e r  0.1 or 1 LD^ Q had died between day 0 
and day 2 8 . The same was t rue  f o r  the group of mice which
Table 7 * Effect of intradermal inoculation of ALS on histoplasmin skin tests in
guinea pigs infected with H. capsulatum
Gudnea 
pig No.
Distance* 
between 
sites, mm
2h hour**
Ind Ery
Distance*** 
between 
sites, mm
2h hour
Ind Ery
1 25 - - 100 10 X 13 10 X 13
2 2 6 - - 100 1 1 X 1 5 1 1 X m-
3 27 - - 100 13 X 14 1 2 X 14
If 30 4- X 5 - 100 10 X 11 10 X 10
5 33 - - 100 8 X 9 8 X 9
6 35 - - 100 8 X 10 8 X 10
7 36 - - 1 0 0 1 2 X 12 12 X 11
8 37 - - 100 9 X 1 2 9 X 12
9 ifO h X 5 100 1 2 X 1 5 12 X 1 5
10 >+8 9 X 18  9  X 1 2 1 0 0 1 2 X 1 5 1 2 X 1 5
*Distance in mm between sites of injection of histoplasmin and ALS, both on
ON
same side.
**Ind = induration; Ery = erythema. (Both measured in mm.); - = negative.
***Distance in mm between sites of injection of histoplasmin and ALS injected 
on different sides.
Table 8. Number of mice dying after infection with C^. neoformans
Treatment
Days
given LD50 Inoc.*
Number dying at week Total dead 
5- weeks1 2 3 4
ALS -1,0,1 1 V 0 2 3 9
ALS -1,0,1 1 V 0 b 1 9
ALS -1,0,1 0.1 V 5 0 1 1 7
ALS -1,0,1 0.1 V 0 0 2 2 4
ALS 0,1,2 1 V 1 1 3 3 8
ALS 7 ,8 , 9 1 V 0 3 5- 2 9
ALS -1,0,1 1 NV 1 0 2 0 3
ALS -1,0,1 None N one 1 0 0 0 1
NRS -1,0,1 1 V 0 0 0 5 5
NRS -1,0,1 0.1 V 0 0 0 2 2
NRS -1,0,1 1 NV 0 0 0 0 0
NRS -1 ,0 , 1 None None 0 0 0 0 0
NRS 7 ,8 , 9 1 V 0 0 5- 1 5
Saline -1,0,1 1 V 0 0 0 !+
Saline -1,0, 1 0.1 V 0 0 0 0 0
ALS - antilymphocyte serum, 0 . 2 5  ml/injection.
NRS = normal rabbit serum, 0 . 2 5  ml/injection.
*V = indicates viable yeast were given; NV = nonviable.
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were in f e c te d  with 1 LD^q but  had no serum t rea tm en t .  After  
28 days a t o t a l  of  mice (75%) which had been in f e c te d  and 
t r e a te d  with  ALS had died out  of  a t o t a l  of  60. During th i s  
same p e r io d ,  12 out of 30 mice (40^) died which were i n ­
fec ted  and t r e a t e d  with NRS. Four of 20 (20^) died which 
were i n f e c te d  and t r e a t e d  with s a l i n e  only.
In  mice t r e a t e d  with ALS on days -1 ,  0, and 1, the 
f i r s t  dea th  occurred w i th in  two days post  i n f e c t i o n .  The 
f i r s t  death  of  a mouse t r e a t e d  with  NRS on the same schedule 
occurred a f t e r  22 days. In mice t r e a t e d  with s a l i n e ,  the 
f i r s t  dea th  occurred 23 days post  i n f e c t i o n .  Table 9 gives 
r e s u l t s  of t h i s  experiment.
I n f e c t i o n  of Mice with  H. capsulatum. Mice in fe c te d  
with a l a rg e  dosage of (10^) y e as t  c e l l s  of  H. capsulatum 
r a p id ly  died i r r e s p e c t i v e  of serum t rea tm en t .  In a group of 
twenty mice t r e a t e d  with  ALS, a l l  mice were dead nine days 
post  i n f e c t i o n .  The f i r s t  death  occurred on day th ree  but  
80^ of  the  deaths were on days s i x  and seven. In mice 
t r e a t e d  with NRS the f i r s t  death  was on day s ix  and 50^ were 
dead by day seven. Unlike mice t r e a t e d  with ALS, were 
s t i l l  l i v i n g  a f t e r  four  weeks.
The group of mice which rece ived  s a l in e  in  p lace  of 
serum a ls o  had 50% f a t a l i t i e s  recorded on days s ix  and 
seven. The f i r s t  death in  t h i s  group occurred on day s ix .  
Ten percen t  of  the mice were a l i v e  a f t e r  th ree  weeks (see 
Table 10).
T a b l e  9 -  D a y  o f  f i r s t  d e a t h  a n d  50% d e a t h  o f  m i c e  i n f e c t e d  w i t h  C .^ n e o f o r m a n s
Treatment
Days
given LD5 0 Inoc*
Day of % dead, 
6 wks1st death 50%> death
ALS - 1 ,0 , 1 1 V 2 17 100
ALS -1 ,0 , 1 0 . 1 V 2 21 85
ALS 0 ,1 , 2 1 V 8 2h 100
ALS 7 ,8 , 9 1 V 1 1 19 100
ALS -1 ,0 , 1 1 NV 5 FO 30
ALS -1,0,1 None None 2 FO 10
NRS -1,0,1 1 V 22 28 90
NRS -1,0,1 0.1 V 22 FO 30
NRS -1,0,1 None None FO** FO 0
NRS 7 ,8 , 9 1 V 15 26 90
NRS -1,0,1 1 NV FO FO 0
Saline -1,0,1 1 V 23 31 60
Saline -1,0,1 0.1 V FO FO 0
ou
\ o
*V - cells given were viable; NV = cells not viable
**F0= event failed to occur during the time allotted
ho
Table 10. Number of mice dying a f t e r  i n f e c t i o n  with
H. capsulatum
Treatment
Days
given
Dosage,
y e as t
c e l l s
Number dying a t  week 
1 2  3 4
Total
dead
ALS - 1 , 0 , 1 10^ 0 0 0 2 2
ALS - 1 , 0 , 1 10^ 0 5* 0 5* 10
ALS - 1 , 0 , 1 107 9 1 0 0 10
ALS - 1 , 0 , 1 10? 10 0 0 0 10
NRS - 1 , 0 , 1 10^ 0 0 0 0 0
NRS - 1 , 0 , 1 10^ 0 5* 0 5* 10
NRS - 1 , 0 , 1 107 8 2 0 0 10
NRS - 1 , 0 , 1 10? 3 4 0 0 7
Sal ine - 1 , 0 , 1 10^ 0 0 0 1 1
Sal ine - 1 , 0 , 1 107 5 3 0 0 8
^These mice were s a c r i f i c e d  fo r  autopsy a t  these
times
ALS = anti lymphocyte serum, 0 .25 m l / i n j e c t i o n .  
NRS = normal r a b b i t  serum, 0.25 m l / i n j e c t i o n .
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In  mice which rece ived  a low number of  c e l l s  (10^),  
no deaths had occurred by the end of th ree  weeks in  any 
group (ALS, NRS, or s a l i n e ) .
Autopsies were performed a t  two and four  weeks post  
i n f e c t i o n  on a d u p l ic a te  s e t  of  mice given 10? y e a s t  c e l l s  
i v .  Mice t r e a t e d  with ALS had a number of c h a r a c t e r i s t i c s  
not  seen i n  mice t r e a t e d  with NRS or s a l i n e .  Their  fu r  was 
r u f f l e d  and they e x h ib i ted  varying degrees of  l e th a r g y .  
Hepatosplenomegaly was common; the spleens were se v e ra l  
times l a r g e r  than those  of the o ther  two groups. The l i v e r s  
o f t e n  were pale  orange and had a mott led  appearance.  C u l tu r ­
ing o f  these organs showed more ex tens ive  invas ion  of  H. 
capsulatum (see Table 11).
S t r ik in g  d i f f e r e n c e s  were found i n  the th ree  groups 
of  mice involved.  Although a l l  mice had rece ived  the same 
number of organisms i n i t i a l l y ,  ALS t r e a t e d  mice ex h ib i ted  
g ro s s ly  h igher  numbers of organisms as determined by colony 
counts on s e r i a l  d i l u t i o n s  of  organ homogenates. In the 
spleens of ALS t r e a t e d  mice, over 150 times as many co lon ies  
were i s o l a t e d  as compared to  spleens of mice t h a t  were 
t r e a t e d  with NRS, and 30 times as many as in  spleens of mice 
t r e a t e d  with s a l i n e .  In  the l i v e r ,  the mean number of  
organisms recovered was 20 times h igher  in  the ALS group 
than in  the NRS group and 11 times t h a t  of  the s a l i n e  group. 
In  the lungs ,  122 times as many organisms were recovered
Table 1 1 . Number of organisms in the spleen, liver, and lungs of mice autopsied
at 2 and 4- weeks after infection with H. capsulatum, iv
Treatment Dosage
Number of colonies x 1o3 after autopsy at
2 weeks 4 weeks
spleen liver lung spleen liver lung
ALS 10^ 1 , 5 6 0 3 , 2 0 0 612 8,274 11,320 2 , 9 1 4
NRS 10^ 10 1 6h 5 130 200 k
Saline 10^ 52 290 3 850 2 , 0 6 8 498
ALS = antilymphocyte serum.
-r
IV)
NRS = normal rabbit serum.
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from the  lungs of ALS t r e a t e d  animals as in  the  NRS group 
and 20^ + times t h a t  of  the s a l i n e  group.
I t  was no t iced  t h a t  on the c u l tu re  p l a t e s  on which 
lung t i s s u e  was p la t e d ,  100^ of the ALS lung t i s s u e  conta ined 
common saprophytic  "contaminants ."  Twenty pe rcen t  of  the 
lung p l a t e s  from mice t r e a t e d  with s a l i n e  showed t h i s  f i n d ­
ing ,  but  no saprophytes were i s o l a t e d  from the lungs of  NRS 
t r e a t e d  mice.
Hemolytic Plaque Assays . Antilymphocyte serum e f -  
f e c t i y e l y  reduced the number of  plaque forming c e l l s  (RFC). 
Only 20^ (6 PFC/10^ lymphoid c e l l s )  as many RFC were formed 
by ALS t r e a t e d  mice compared to  s a l in e  co n t ro l s  (30 RFC/10^ 
lymphoid c e l l s ) .  Normal r a b b i t  serum t r e a t e d  mice a lso  
showed some depress ion  (15 RFC/10° lymphoid c e l l s ) .  These 
f in d in g s  were in  agreement with Barth  e t  a l .  (4) who found 
marked depress ion  of RFC in  ALS t r e a t e d  mice and moderate 
d e p re ss io n  in  NRS t r e a t e d  mice. About 30 times as many 
plaques were demonstrated by Barth  e t  a l .  ( k )  s ince  they used 
primed mice whereas non-primed mice were used in  the p resen t  
s tudy.
CHAPTER IV 
DISCUSSION
The antilymphocyte se ra  produced fo r  t h i s  s tudy were 
e f f e c t i v e  immunosuppressants. The fol lowing f a c t s  concerning 
anti -mouse and/or  a n t i -g u in e a  pig ALS po in t  to  such e f f e c ­
t iv e n e s s :  1. S u b s tan t ia l  l e u c o a g g lu t in a t io n  t i t e r s  were
demonstrated. 2. Cytotoxic a c t i v i t y  was p re s e n t .  3* Mod­
e ra te  i n h i b i t i o n  of plaque forming, an tibody producing c e l l s  
was observed, k .  Suppression of delayed sk in  t e s t  r e ­
a c t i v i t y  both sys tem ica l ly  and local] .y  was demonstrated.
5. Marked lymphopénie producing a b i l i t y  was shown.
No serum has ye t  been found which had immunosup­
p res s iv e  p r o p e r t i e s  unless  t h a t  serum a lso  possessed 
l e u c o a g g lu t in a t in g  a b i l i t y  (25) .  There i s  no i n  v i t r o  assay 
method fo r  predetermining the e f f e c t iv e n e s s  of a p a r t i c u l a r  
an t ise rum , but  one or more of the f iv e  po in ts  l i s t e d  above 
have been c h a r a c t e r i s t i c a l l y  p re sen t  in  e f f i c a c io u s  a n t i s e r a  
prepared by var ious  workers.
In t h i s  study i t  was shown t h a t  t rea tm ent  with  ALS 
had a marked e f f e c t  on m o r ta l i ty  produced by experimental  
i n f e c t i o n .  F i f t y  percent  of  the  guinea pigs which were
1+4
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t r e a t e d  weekly with ALS died during the  s tudy.  Two of seven 
c o n t ro l  animals which were t r e a t e d  only with ALS a lso  d ied .  
Autopsies on these  two animals in d ic a t e d  t h a t  death  r e s u l t e d  
from a septicemic con d i t io n  caused by Pseudomonas sp e c ie s .  
These f ind ings  in d ic a te d  t h a t  exper im en ta l ly  in fe c te d  guinea 
pigs t r e a t e d  weekly with ALS were more prone to  develop 
f a t a l  i n f e c t i o n s .  Weekly t rea tm ent  of  c o n tro l  guinea pigs 
with ALS a ls o  seemed to  predispose  them to i n f e c t i o n  from 
organisms in  the environment.
Findings in  mice were s i m i l a r .  Mice t r e a t e d  with 
ALS and given 1 LD^q of  Ç. neoformans d ied much sooner than 
in f e c te d  con t ro l s  given NRS or s a l i n e .  Mice given 0.1 LD^ Q 
and ALS had 80^ deaths a t  the end of 28 days whereas mice 
given s a l in e  and the same number o f  c e l l s  had no deaths 
during the same per iod .  Those mice which died ex h ib i ted  the 
c h a r a c t e r i s t i c  o c c i p i t a l  bulging caused by increased  i n t r a -  
c e re b ra l  p ressure  produced in  cryptococcosis . The b ra ins  of 
such mice were c u l t u r a l l y  p o s i t iv e  f o r  Ç. neoformans. Mice 
which were not  exper im enta l ly  i n f e c te d  but  were t r e a t e d  with 
ALS were not more su s c e p t ib le  to observable  i n f e c t i o n  from 
agents  in  the environment than were normal, u n t rea te d  con­
t r o l  mice.
The in fe rence  drawn from t h i s  p r e d i s p o s i t i o n  to 
m o r ta l i t y  was t h a t  ALS presumably i n h i b i t e d  or destroyed 
antibody forming c e l l s  which would have o r d i n a r i l y  become 
committed to the i n f e c t i n g  organism. The hypothes is  of
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" s t e r i l e  a c t iv a t io n "  ( 18 ) might e x p la in  such a lo s s  of com­
mitment. This hypo thes is  i s  based on the obse rva t ion  t h a t  
some lymphoid c e l l s  when exposed to  ALS t rans fo rm  in to  b l a s t  
c e l l s .  Perhaps, then,  c e r t a i n  lymphocytes were ready to 
recognize  a fo re ig n  a n t ig en .  When th ese  c e l l s  were exposed 
to  ALS they transformed in to  b l a s t s .  This rendered them 
incapable  of recogniz ing  any fo re ig n  a n t ig en .
An i n t e r e s t i n g ,  though pe rp lex ing ,  phenomenon 
fo l low s:  Nine of 40 mice { 2 2 . S%) i n f e c t e d  with 0.1 or
1 LD^q of Ç. neoformans and t r e a t e d  with  ALS on days -1 ,  0, 
and 1 died on the second post  i n f e c t i o n  day. This did not  
occur in  mice t h a t  rece ived  ALS and k i l l e d  c e l l s  or in  mice 
which were in fe c te d  but  got ALS on days 0, 1, and 2. Neither  
did i t  occur in  mice t h a t  rece ived  ALS on days -1 ,  0, and 1 
and were in fe c te d  with  H. capsulatum, even though 100^ of 
the mice in  the group which received  10? c e l l s  were dead 
w i th in  nine days post  i n f e c t i o n  (much more quickly  than with 
the h igh dose of C. neoformans). Ne i the r  ALS nor Ç. 
neoformans a lone ,  in  the amounts used h e re ,  caused death  in  
two days, but  the combination of the two d id .  There can be 
no doubt t h a t  ALS caused a good deal  of p h y s io lo g ic a l  
s t r e s s ,  as evidenced by extreme l e t h a r g y ,  r u f f l e d  f u r ,  
d i a r r h e a ,  and weight lo s s  which accompanied ALS t rea tm en t .  
Perhaps the s t r e s s  so c re a te d ,  plus some unknown c o n t r ib u ­
t i o n  from the v i a b le  y e a s t  c e l l s  were s u f f i c i e n t  cause fo r  
d ea th .  Five a d d i t i o n a l  mice died during the fol lowing f iv e
k 7
days bu t  no deaths occurred fo r  the next  e ig h t  days. The 
next group of deaths occurred then ,  but  t h a t  was the 
expected r e s u l t  of  i n f e c t i o n  a l though  i t  occurred one week 
e a r l i e r  than  in fe c te d  c o n t ro l  mice given NRS or s a l i n e .
The lymphopenia produced in  guinea pigs was severe 
but  t r a n s i e n t  d e sp i te  weekly t rea tm en t  with  ALS. This could 
be exp la ined  by the f a c t  t h a t  r e l a t i v e l y  small  doses were 
given. Since ALS i s  immunogenic, small doses may have been 
i n s u f f i c i e n t  to  suppress the formation of an t ibody  a g a in s t  
i t s e l f .  An anti-ALS would then r e s u l t .  This was i n  f a c t  
shown i n  t h i s  study using p r e c i p i t a t i o n  in  agar  g e l .  Thus, 
subsequent in o cu la t io n s  of  ALS must have r e s u l t e d  in  i t s  
own removal by the process of immune e l im in a t io n .  I f  l a rg e  
doses of ALS were given i n i t i a l l y  t h i s  might suppress a n t i ­
body format ion  a g a in s t  i t s e l f  and a durable  lymphopenia 
might have r e s u l t e d .
The p e r ip h e ra l  lymphocyte count c o r r e l a t e d  roughly 
with the  ex te n t  of suppress ion  of delayed h y p e rs e n s i t iv e  
r e a c t i o n s .  Waksman e t  a l .  (30) showed some c o r r e l a t i o n  be­
tween the ex ten t  of i n d u ra t io n  and lymphocyte count in  the 
delayed tu b e rc u l in  r e a c t i o n .  Russe l l  and Monaco (26) 
demonstrated a r e l a t i o n s h i p  between depressed lymphocyte 
counts  and p ro longa t ion  of  g r a f t  su r v iv a l .  These workers 
a l s o  r ep o r te d  t h a t  t i s s u e  lymphopénie recovery  was r e ­
f l e c t e d  by recovery from blood lymphopenia. Adm inis tra t ion  
of  ALS r e s u l t e d  in  a remarkable reduc t ion  of  p e r ip h e ra l  and
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c e n t r a l  lymphocytes which, in  t u rn ,  r e s u l t e d  in  suppress ion  
of the delayed, r e a c t io n  whether i t  be abrogat ion  of  sk in  
h y p e r s e n s i t i v i t y  or p ro longa t ion  of g r a f t  s u r v iv a l .
The mechanism resp o n s ib le  f o r  the delayed sk in  r e ­
ac t io n  i s  sp e cu la to ry .  According to McCluskey e t  a l .  (20) 
and Feldman e t  a l .  (8) two s teps  a re  involved in  the delayed 
r e a c t io n .  The i n i t i a l  s tep  i s  iramunologically s p e c i f i c  and 
involves r e l a t i v e l y  few lymphoid c e l l s ,  probably lymphocytes, 
which have been a l t e r e d  [committed] by a f i r s t  exposure to 
a n t igen  and which, upon re-exposure  to the a n t igen ,  t r i g g e r  
an in f lam atory  response.  The second s tep  i s  a nonspec i f ic  
accumulation of mononuclear c e l l s  such as b l a s t  c e l l s ,  
o ther  lymphocytes and monocytes.
The i n h i b i t i o n  of delayed sk in  t e s t  r e a c t i v i t y  by 
RAGPLS in  t h i s  study was l i k e l y  due to the e f f e c t s  of t h i s  
an tiserum on committed lymphocytes involved in  the  i n i t i a l  
phase of  delayed h y p e r s e n s i t i v i t y .  These c e l l s  may be 
coated or "b l indfo lded"  with the g lob u l in  p o r t io n  of  ALS 
( 17) j or perhaps lysed  in  the presence of complement. Re­
g ard less  of the mechanism of i n a c t i v a t i o n  of committed 
lymphocytes, i n h i b i t i o n  of  sk in  r e a c t i v i t y  would r e s u l t  
s ince an i n s u f f i c i e n t  number of lymphocytes would be a v a i l ­
able  to  t r i g g e r  the mechanism.
This s i t u a t i o n  was somewhat more e a s i l y  seen when 
ALS was given id .  One-tenth ml of ALS in je c te d  id  had an 
e f f e c t i v e  rad iu s  of about  40 mm. When h is top lasm in  was
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in je c t e d  id  in to  an area  l e s s  than 40 mm d i s t a n t  from the 
ALS s i t e ,  i t  may have been t h a t  lymphocytes which were-com­
mit ted  to H. cansulatum (or  i t s  by-products  such as h i s t o ­
plasmin) would be drawn to the area  (uncommitted lymphocytes 
which wander i n to  the area  would a l s o  be a f f e c te d )  and were 
ac ted  upon by ALS. Once these c e l l s  were in a c t iv a te d  they 
became incapable  of t r i g g e r i r g  the f j . r s t  s tage  of the delayed 
r e a c t io n .  This system bears  f u r t h e r  i n v e s t i g a t i o n  to de­
termine how ALS was ab le  to i n h i b i t  delayed type r e a c t io n s  
over such a v a s t  a rea  of t i s s u e  s ince  one might assume t h a t
ALS would be bound to var ious  c e l l s  shar ing  an t igens  in
common with lymphoid c e l l s .  This would tend to r e s t r i c t  the 
d i f f u s io n  of  ALS to  an area  c lose  to i t s  s i t e  of i n j e c t i o n .  
This might be expla ined  by reasoning t h a t  ALS perhaps a t ­
tached to m igra t ing  lymphoid c e l l s  (as has been shown to 
occur in  v i t r o )  (29. 33) which migrated fo r  some d is tance  
before they became in c a p a c i t a te d  through the a c t io n  of ALS. 
These c e l l s ,  through c lose  a s s o c i a t i o n ,  may have become ad­
h e re n t  to o ther  c e l l s  in  the a rea  due to the g lobu l in  coa t ing  
the former c e l l ' s  su r face .
The mode of a c t io n  of ALS i s  a lso  deba tab le .  Per iph­
e r a l  c i r c u l a t i n g  lymphocytes may be coated with ALS iui vivo 
and these  coated c e l l s  a re  probably then sub jec ted  to  a 
shortened l i f e  span, presumably by phagocytosis  or opsoni­
z a t io n  in  the sp leen  and l i v e r .  Consequently, the p e r ip h e ra l  
c i r c u l a t i n g  lymphocyte pool i s  d ra m a t ic a l ly  reduced. This i s
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the pool which i s  concerned with c e l l u l a r  and a l l o g r a f t  im­
munit ies  and t h i s  i s  the reason t h a t  ALS works so well  in  
these  immunities (A. P. Monaco, pe rsona l  communication).
Denman and Frenkel  (6 ) ,  using autoradiography and 
immunofluorescence showed only l im i te d  p e n e t r a t io n  of ALS 
i n to  sp leen ,  thymus, and lymph nodes. This might be i n ­
t e r p r e t e d  to  mean t h a t  ALS was most e f f e c t i v e  on p e r ip h e ra l  
lymphocytes r a t h e r  than  on those w i th in  lymphoid t i s s u e .
Even so, Barth  e t  a l .  (L) r ep o r ted  d iminut ion  of lymphoid 
c e l l s  inc lud ing  plaque forming c e l l s  in  sp len ic  t i s s u e  f o l ­
lowing ALS t rea tm en t .  Although t h i s  co n d i t io n  p e r s i s t e d  in  
the  sp leen  during a secondary response ,  no e f f e c t  on 
secondary antibody response to sheep red  blood c e l l s  could 
be achieved with ALS. Thus, a l though  i t  has been claimed 
t h a t  lymphopenia may not be e s s e n t i a l  fo r  success fu l  im­
munosuppression ( 15 ) some workers have noted a c lose  c o r r e ­
l a t i o n  between lymphopenia and homograft r e t e n t i o n  ( 14) .
The changes which occurred i n  sp le n ic  t i s s u e ,  as 
mentioned above, may p lay a r o le  in  the extreme  p r o l i f e r a ­
t i o n  of H. capsulatum which occurred i n  va r ious  organs of 
ALS t r e a t e d  mice. This tremendous in c re a s e  in  the ex te n t  of 
t i s s u e  invas ion  provides some evidence t h a t  the c e l l u l a r  
immune response i s  an important  defense  mechanism in  l i m i t ­
ing h is top lasm osis  to  i t s  t y p i c a l l y  benign form. Such an 
i n f e c t i o n  in  ALS t r e a t e d  mice may wel l  be a t t r i b u t e d  to an 
a l t e r e d  a b i l i t y  of the ho s t  to respond i n  an immunologically
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normal fash ion .  This impairment of  the immune system does 
not  stem from competi t ion of  an t igens  ( i . e .  ALS with H. 
capsulatum y e a s t  c e l l s )  fo r  i f  t h i s  were so, mice t r e a te d  
with  NRS should have more—not fewer—organisms/organ than 
those  mice t r e a t e d  with s a l i n e .  In f a c t ,  NRS seemed to 
have a mild i n h ib i t o r y  e f f e c t  in  t h i s  in s tan c e  which was in  
accordance with the f in d in g  t h a t  no saprophyt ic  fungi were 
i s o l a t e d  from the lungs of mice t r e a t e d  with NRS. Ob­
v io u s ly ,  va r ious  fungal spores commonly p re sen t  in  the en­
vironment were c o n t in u a l ly  being inha led  by these  mice but 
the r e s u l t s  of  au to p s ie s  in d ic a te d  t h a t  these  common 
saprophytes do not  p r o l i f e r a t e  to  any g re a t  e x te n t  a f t e r  
access  to  the lung. This s i t u a t i o n  did not  seem to p re v a i l  
in  mice t r e a te d  with ALS. Such o p p o r tu n is t i c  growth may 
have r e s u l t e d  from trea tm en t  with ALS and/or  be due to the 
d i b i l i t a t e d  na tu re  of  the h o s t  which stemmed from i n f e c t i o n  
with H. capsulatum.
CHAPTER V 
SUMMARY AND CONCLUSIONS
The anti-mouse and a n t i -g u in e a  pig anti thymocyte  
se ra  prepared fo r  t h i s  study were shown to con ta in  cy to tox ic  
and leu c o a g g lu t in a t in g  a n t ib o d ie s ,  and were capable of pro­
ducing severe lymphopenia in  these  animals .  The anti-mouse 
ALS was a lso  shown to cause a r ed u c t io n  in  the number of 
plaque forming c e l l s  when the h em o lys is - in -g e l  plaque assay  
system was used.
I t  was found t h a t  guinea pigs t r e a te d  weekly with 
ALS were more s u s c e p t ib le  to development of f a t a l  i n f e c t i o n  
when inocu la ted  with  H. capsulatum. Guinea pigs which were 
t r e a t e d  weekly with  ALS but not exper im en ta l ly  in fe c te d  were 
more su s ce p t ib le  to i n f e c t i o n  from organisms in  the  environ­
ment than normal con tro l  animals. No f a t a l i t i e s  occurred in  
guinea pigs in fe c te d  with equal doses of H. capsulatum but 
t r e a t e d  with NRS or s a l in e  r a th e r  than ALS.
The time necessary  to reach $0^ f a t a l i t y  in  mice i n ­
fe c te d  with Ç. neoformans was g r e a t l y  reduced by p re t rea tm ent  
with ALS compared to in fec te d  c o n t ro l s  t r e a t e d  with NRS or
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s a l i n e .  When low dosages were used (0.1 LD^q) a s im i la r  
p a t t e r n  emerged but the e f f e c t  was even more s t r i k i n g .
Cul tur ing of sp leen  homogenates from mice inocula ted  
ip  with H. capsulatum showed t h a t  more than  150 times as 
many organisms were p re sen t  than in  the spleens of  con tro l  
mice t h a t  rece ived  the same i n f e c t i v e  dose but  were t r e a te d  
with normal r a b b i t  serum. S imilar  r e s u l t s  were obtained 
from c u l tu r in g  the lungs but  to a l e s s e r  degree.  More 
organisms were recovered from the l i v e r  than from the spleen 
r e g a rd le s s  of the type of t rea tm ent  (ALS, NRS, or s a l i n e ) .
The lungs conta ined the fewest  number of organisms.
Delayed h y p e r s e n s i t iv e  sk in  r e a c t io n s  were r a d i c a l l y  
decreased or abrogated in  H. capsulatum in f e c te d  guinea pigs 
inocu la ted  i n t r a p e r i t o n e a l l y  12 hours before sk in  t e s t i n g  
with h is top la sm in .  When ALS was given weekly the in f luence  
on sk in  r e a c t i v i t y  was l e s s  n o tab le .  Given in t r a d e r m a l l y ,
ALS was shown to i n h i b i t  the delayed r e a c t i o n  to h is top lasm in  
w i th in  a rad ius  of 40 mm.
The p r in c ip a l  conclusions from t h i s  s tudy  were:
1. Animals t r e a te d  with ALS s h o r t ly  before  and a f t e r  ex­
perimenta l  i n f e c t i o n  were f a r  more l i k e l y  to develop f a t a l  
i n f e c t io n s  than c o n t ro l  animals .  2. F a t a l i t y  was g r e a t ly  
a c c e le ra te d  by t rea tm ent  with ALS. 3 . R e la t iv e ly  low 
doses of Ç. neoformans (innocuous to  s a l i n e  t r e a t e d  mice) 
r a p id ly  k i l l e d  mice t r e a t e d  with ALS. 4. No impairment 
of  humoral antibody product ion  was observed but  c e l l u l a r
5^
immunity was a f f e c t e d .  I t  appeared l i k e l y  th a t  t h i s  im­
pairment of  c e l l u l a r  defense r e s u l t e d  in  much h igher  mor­
t a l i t y  r a t e s  i n  animals t r e a t e d  with ALS. 5* Delayed 
h y p e rs e n s i t iv e  sk in  r e a c t io n s  can be depressed or abrogated  
by ip  or id  t rea tm ent  with ALS. 6. A moderate l e u c o c y to s i s  
r e s u l t e d  from weekly t rea tm en t  with  ALS and was s im i l a r  to 
t h a t  of  H. capsulatum in f e c te d  guinea pigs t r e a t e d  with  ALS. 
I n f e c t i o n  a lone r e s u l t e d  only in  a s l i g h t  and t r a n s i e n t  
l e u c o c y to s i s .  ? . Antilymphocyte serum in  guinea pigs 
caused a severe but  t r a n s i e n t  lymphopenia. I n f e c t io n  by
H. capsulatum i n  ALS t r e a t e d  animals slowed the r e t u r n  of 
lymphopenia toward normal v a l u e s .
I t  i s  suggested t h a t  ALS o f f e r s  a u se fu l  to o l  for  
immunological i n v e s t i g a t io n s  i n  animals which a re  e x p e r i ­
mental ly  t r e a t e d  with var ious  microbia l  agen ts .  Such 
s tu d ie s  might inc lude  s e l e c t i v e  i n h i b i t i o n  of c e l l u l a r  
immune mechanisms mediated by p e r ip h e ra l  c i r c u l a t i n g  lympho­
cy tes  and the  subsequent e f f e c t  on v i ru lence  and su rv iv a l  of 
the  t e s t  organism used. Antilymphocyte serum might a l s o  be 
of value as a means of in c re a s in g  s u s c e p t i b i l i t y  of  animals 
to  va r ious  " o p p o r tu n is t i c "  microorganisms which possess 
l im i t e d  c a p a b i l i t y  to  cause i n f e c t i o n .
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